Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics
Xu, Kailun; Yin, Xiaoyang; Chen, Hui; Huang, Yuhui; Zheng, Xi; Zhou, Biting; Cai, Xue; Gao, Huanhuan; Tian, Miaomiao; Hu, Sijun; Zheng, Shu; Yuan, Changzheng; Nie, Yongzhan; Guo, Tiannan; Shao, Yingkuan Share Save Share Save Share Save Share Save Share Save Surufatinib plus doublet (FOLFOX/FOLFIRI) or triplet (FOLFOXIRI) chemotherapy as second-line therapy in metastatic colorectal cancer (mCRC): First-stage results of a randomized, open-label phase II trialLin, R.; Li, H.; Chen, X.; Zheng, L.; Hong, Y.; Su, L.; Li, C.; Zheng, S.; Su, L. Share Save FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patientsXu, Kailun; Yin, Xiaoyang; Zhou, Biting; Zheng, Xi; Wang, Hao; Chen, Jing; Cai, Xue; Gao, Huanhuan; Xu, Xiaoming; Wang, Liuhong; Shen, Li; Guo, Tiannan; Zheng, Shu; Li, Baosheng; Shao, Yingkuan; Wang, Jian Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
